1
|
Claesson TB, Putaala J, Shams S, Salli E, Gordin D, Mutter S, Tatlisumak T, Groop PH, Martola J, Thorn LM. Cerebral Small Vessel Disease Is Associated With Smaller Brain Volumes in Adults With Type 1 Diabetes. J Diabetes Res 2024; 2024:5525213. [PMID: 38984211 PMCID: PMC11233188 DOI: 10.1155/2024/5525213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 03/25/2024] [Accepted: 06/14/2024] [Indexed: 07/11/2024] Open
Abstract
Introduction: Type 1 diabetes has been linked to brain volume reductions as well as to cerebral small vessel disease (cSVD). This study concerns the relationship between normalized brain volumes (volume fractions) and cSVD, which has not been examined previously. Methods: We subjected brain magnetic resonance imaging studies of 187 adults of both sexes with Type 1 diabetes and 30 matched controls to volumetry and neuroradiological interpretation. Results: Participants with Type 1 diabetes had smaller thalami compared to controls without diabetes (p = 0.034). In subgroup analysis of the Type 1 diabetes group, having any sign of cSVD was associated with smaller cortical (p = 0.031) and deep gray matter volume fractions (p = 0.029), but a larger white matter volume fraction (p = 0.048). After correcting for age, the smaller putamen volume remained significant. Conclusions: We found smaller thalamus volume fractions in individuals with Type 1 diabetes as compared to those without diabetes, as well as reductions in brain volume fractions related to signs of cSVD in individuals with Type 1 diabetes.
Collapse
Affiliation(s)
- Tor-björn Claesson
- Department of Radiology/HUS Medical Imaging CentreUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Folkhälsan Institute of GeneticsFolkhälsan Research Center, Helsinki, Finland
- Department of NephrologyUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Research Program for Clinical and Molecular MetabolismFaculty of MedicineUniversity of Helsinki, Helsinki, Finland
| | - Jukka Putaala
- Department of NeurologyHelsinki University Hospital and University of Helsinki, Helsinki, Finland
| | - Sara Shams
- Department of RadiologyKarolinska University Hospital, Stockholm, Sweden
- Department of Clinical NeuroscienceKarolinska Institute, Stockholm, Sweden
- Department of RadiologyStanford University, Stanford, California, USA
| | - Eero Salli
- Department of Radiology/HUS Medical Imaging CentreUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - Daniel Gordin
- Folkhälsan Institute of GeneticsFolkhälsan Research Center, Helsinki, Finland
- Department of NephrologyUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Research Program for Clinical and Molecular MetabolismFaculty of MedicineUniversity of Helsinki, Helsinki, Finland
- Joslin Diabetes CenterHarvard Medical School, Boston, Massachusetts, USA
| | - Stefan Mutter
- Folkhälsan Institute of GeneticsFolkhälsan Research Center, Helsinki, Finland
- Department of NephrologyUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Research Program for Clinical and Molecular MetabolismFaculty of MedicineUniversity of Helsinki, Helsinki, Finland
| | - Turgut Tatlisumak
- Department of NeurologyHelsinki University Hospital and University of Helsinki, Helsinki, Finland
- Department of Clinical Neuroscience/NeurologyInstitute of Neuroscience and PhysiologySahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
- Department of NeurologySahlgrenska University Hospital, Gothenburg, Sweden
| | - Per-Henrik Groop
- Folkhälsan Institute of GeneticsFolkhälsan Research Center, Helsinki, Finland
- Department of NephrologyUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Research Program for Clinical and Molecular MetabolismFaculty of MedicineUniversity of Helsinki, Helsinki, Finland
- Department of DiabetesCentral Clinical SchoolMonash University, Melbourne, Australia
| | - Juha Martola
- Department of Radiology/HUS Medical Imaging CentreUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Department of RadiologyKarolinska University Hospital, Stockholm, Sweden
| | - Lena M. Thorn
- Folkhälsan Institute of GeneticsFolkhälsan Research Center, Helsinki, Finland
- Research Program for Clinical and Molecular MetabolismFaculty of MedicineUniversity of Helsinki, Helsinki, Finland
- Department of General Practice and Primary Health CareUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland
| |
Collapse
|
2
|
Aghjayan SL, Lesnovskaya A, Esteban-Cornejo I, Peven JC, Stillman CM, Erickson KI. Aerobic exercise, cardiorespiratory fitness, and the human hippocampus. Hippocampus 2021; 31:817-844. [PMID: 34101305 PMCID: PMC8295234 DOI: 10.1002/hipo.23337] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 04/22/2021] [Accepted: 04/25/2021] [Indexed: 01/27/2023]
Abstract
The hippocampus is particularly susceptible to neurodegeneration. Physical activity, specifically increasing cardiorespiratory fitness via aerobic exercise, shows promise as a potential method for mitigating hippocampal decline in humans. Numerous studies have now investigated associations between the structure and function of the hippocampus and engagement in physical activity. Still, there remains continued debate and confusion about the relationship between physical activity and the human hippocampus. In this review, we describe the current state of the physical activity and exercise literature as it pertains to the structure and function of the human hippocampus, focusing on four magnetic resonance imaging measures: volume, diffusion tensor imaging, resting-state functional connectivity, and perfusion. We conclude that, despite significant heterogeneity in study methods, populations of interest, and scope, there are consistent positive findings, suggesting a promising role for physical activity in promoting hippocampal structure and function throughout the lifespan.
Collapse
Affiliation(s)
- Sarah L Aghjayan
- Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.,Center for the Neural Basis of Cognition, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Alina Lesnovskaya
- Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.,Center for the Neural Basis of Cognition, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Irene Esteban-Cornejo
- PROFITH "PROmoting FITness and Health Through Physical Activity" Research Group, Sport and Health University Research Institute (iMUDS), Department of Physical Education and Sports, Faculty of Sport Sciences, University of Granada, Granada, Spain.,College of Science, Health, Engineering, and Education, Murdoch University, Perth, Western Australia
| | - Jamie C Peven
- Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.,Center for the Neural Basis of Cognition, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Chelsea M Stillman
- Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Kirk I Erickson
- Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.,Center for the Neural Basis of Cognition, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.,College of Science, Health, Engineering, and Education, Murdoch University, Perth, Western Australia
| |
Collapse
|
3
|
Hall PA, Bickel WK, Erickson KI, Wagner DD. Neuroimaging, neuromodulation, and population health: the neuroscience of chronic disease prevention. Ann N Y Acad Sci 2018; 1428:240-256. [PMID: 29863790 PMCID: PMC6175225 DOI: 10.1111/nyas.13868] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2017] [Revised: 04/24/2018] [Accepted: 05/04/2018] [Indexed: 01/10/2023]
Abstract
Preventable chronic diseases are the leading cause of death in the majority of countries throughout the world, and this trend will continue for the foreseeable future. The potential to offset the social, economic, and personal burdens associated with such conditions depends on our ability to influence people's thought processes, decisions, and behaviors, all of which can be understood with reference to the brain itself. Within the health neuroscience framework, the brain can be viewed as a predictor, mediator, moderator, or outcome in relation to health-related phenomena. This review explores examples of each of these, with specific reference to the primary prevention (i.e., prevention of initial onset) of chronic diseases. Within the topic of primary prevention, we touch on several cross-cutting themes (persuasive communications, delay discounting of rewards, and self-control), and place a special focus on obesity as a disorder influenced by both eating behavior and exercise habits.
Collapse
Affiliation(s)
- Peter A. Hall
- School of Public Health and Health SystemsUniversity of WaterlooWaterlooOntarioCanada
| | - Warren K. Bickel
- Departments of PsychologyNeuroscience and Health Sciences, Virginia TechRoanokeVirginia
| | - Kirk I. Erickson
- Department of PsychologyUniversity of PittsburghPittsburghPennsylvania
| | | |
Collapse
|
4
|
Kirschen GW, Kéry R, Ge S. The Hippocampal Neuro-Glio-Vascular Network: Metabolic Vulnerability and Potential Neurogenic Regeneration in Disease. Brain Plast 2018; 3:129-144. [PMID: 30151338 PMCID: PMC6091038 DOI: 10.3233/bpl-170055] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Brain metabolism is a fragile balance between nutrient/oxygen supply provided by the blood and neuronal/glial demand. Small perturbations in these parameters are necessary for proper homeostatic functioning and information processing, but can also cause significant damage and cell death if dysregulated. During embryonic and early post-natal development, massive neurogenesis occurs, a process that continues at a limited rate in adulthood in two neurogenic niches, one in the lateral ventricle and the other in the hippocampal dentate gyrus. When metabolic demand does not correspond with supply, which can occur dramatically in the case of hypoxia or ischemia, or more subtly in the case of neuropsychiatric or neurodegenerative disorders, both of these neurogenic niches can respond—either in a beneficial manner, to regenerate damaged or lost tissue, or in a detrimental fashion—creating aberrant synaptic connections. In this review, we focus on the complex relationship that exists between the cerebral vasculature and neurogenesis across development and in disease states including hypoxic-ischemic injury, hypertension, diabetes mellitus, and Alzheimer’s disease. Although there is still much to be elucidated, we are beginning to appreciate how neurogenesis may help or harm the metabolically-injured brain, in the hopes that these insights can be used to tailor novel therapeutics to regenerate damaged tissue after injury.
Collapse
Affiliation(s)
- Gregory W Kirschen
- Medical Scientist Training Program (MSTP), Stony Brook Medicine, Stony Brook, NY, USA.,Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, NY, USA
| | - Rachel Kéry
- Medical Scientist Training Program (MSTP), Stony Brook Medicine, Stony Brook, NY, USA.,Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, NY, USA
| | - Shaoyu Ge
- Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, NY, USA
| |
Collapse
|